Publications by authors named "Tim Keuler"

Claim this Profile
C
Crosstalk between NLRP3 Signaling and Histone Deacetylases in Inflammasome-Driven Diseases.
Kathrin Tan, M Mercedes Rodríguez-Fernández, Tim Keuler, Finn K Hansen, Michael Gütschow

J Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degrading the key component of the inflammasome: development of an NLRP3 PROTAC.
Tim Keuler, Dominic Ferber, Jonas Engelhardt, Christian Steinebach, Nico Kirsch

Chem Commun (Camb)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorogenic substrates and pre-column derivatization for monitoring the activity of bile salt hydrolase from Clostridium perfringens.
Tim Keuler, Valentina Wolf, Carina Lemke, Rabea Voget, Annett Braune

Bioorg Chem· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accessing three-branched high-affinity cereblon ligands for molecular glue and protein degrader design.
Robert Kuchta, Christopher Heim, Alexander Herrmann, Samuel Maiwald, Yuen Lam Dora Ng, Tim Keuler

RSC Chem Biol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents.
Tim Keuler, Carina Lemke, Paul W Elsinghorst, Isabel Iriepa, Mourad Chioua

ACS Pharmacol Transl Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the first non-hydroxamate selective HDAC6 degraders.
Tim Keuler, Beate König, Nico Bückreiß, Fabian B Kraft, Philipp König

Chem Commun (Camb)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Stability Relationship of NLRP3 Inflammasome-Inhibiting Sulfonylureas.
Tim Keuler, Dominic Ferber, Michael Marleaux, Matthias Geyer, Michael Gütschow

ACS Omega· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors.
Laura Schäkel, Salahuddin Mirza, Markus Pietsch, Sang-Yong Lee, Tim Keuler

Arch Pharm (Weinheim)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Fluorescent and Biotin Probes Targeting NLRP3.
Tim Keuler, Karl Gatterdam, Anil Akbal, Marta Lovotti, Michael Marleaux

Front Chem· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis